Opto Circuits (India) is currently trading at Rs. 206.20, up by 11.60 points or 5.96% from its previous closing of Rs. 194.60 on the BSE.
The scrip opened at Rs. 191.20 and has touched a high and low of Rs. 207.30 and Rs. 190.00 respectively. So far 1,99,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 310.40 on 09-May-2011 and a 52 week low of Rs. 187.00 on 07-Oct-2011.
Last one week high and low of the scrip stood at Rs. 207.30 and Rs. 189.00 respectively. The current market cap of the company is Rs. 3,843.00 crore.
The promoters holding in the company stood at 28.05% while Institutions and Non-Institutions held 39.46% and 32.49% respectively.
Opto Circuits’ subsidiary and a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, Cardiac Science Corporation, has tied an agreement to provide 151 Powerheart AED G3 Pro units to the Hong Kong Department of Health (DH). Pacific Medical Systems, Cardiac Science's exclusive distribution partner in Hong Kong, worked closely with the DH to secure the agreement.
Opto Circuits is proud that the Hong Kong Department of Health has chosen Cardiac Science AEDs to combat sudden cardiac arrest (SCA). The units, which will be fully deployed by year’s end, will be available for medical professionals in government medical clinics throughout the region.
This alliance demonstrates the trend the company is witnessing across the globe that Governments are increasingly deploying AEDs in public buildings to save lives. The Powerheart AED G3 Pro is a fully equipped AED for medical professionals and features a color display, 3-lead ECG monitoring capability, and manual defibrillation override.
Opto Circuits India (OCI) is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 540.05 |
| Poly Medicure | 1491.75 |
| Laxmi Denta | 198.70 |
| Nureca Ltd. | 261.10 |
| Hemant Surgical Inds | 310.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: